Physician profile
Peggy S Wright
NPI 1750554994
$631.74
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $604 · 2022: $27.51.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $161.08 | 2021 | |
| Boston Scientific Corporation | $69.44 | 2021 | |
| Almatica Pharma LLC | $67.45 | 2021 | |
| Arbor Pharmaceuticals, INC. | $53.21 | 2021 | |
| Abbott Laboratories | $42.57 | 2021 | |
| Novartis Pharmaceuticals Corporation | $37.34 | 2021 | |
| Virtus Pharmaceuticals LLC | $28.09 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $27.51 | 2022 | |
| Nevro Corp. | $24.66 | 2021 | |
| Biodelivery Sciences International, INC. | $24.44 | 2021 | |
| Pfizer INC. | $19.23 | 2021 | |
| Lilly USA, LLC | $16.71 | 2021 | |
| Vertos Medical, INC. | $16.62 | 2021 | |
| Medtronic, INC. | $15.59 | 2021 | |
| Eisai INC. | $15.02 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $12.78 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peggy Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.